If you have been reading about incretin receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-07. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Aminoglycoside resistance is generally mediated by a resistance gene that inactivates the antibiotic via chemical modification. A wide range of such aminoglycoside modifying enzymes are known, including nucleotidyltranferases, phosphotransferases, or acetyltransferases: all enzymes that attach extra chemical groups to the molecule. New antibiotics have been developed based on the knowledge of some of these enzymes, incorporating structural changes that prevent specific groups of resistance enzymes from modifying the drug.
When one German soldier was shot and one seriously wounded in Pancevo, Wehrmacht soldiers and the Waffen SS rounded up about 100 civilians at random...the town commander, Lt. Col. Fritz Bandelow conducted the Courts Martial...The presiding judge, SS-Sturmbannführer Rudolf Hoffmann sentenced 36 of those arrested to death. On April 21, 1941, four of the civilians were the first to be shot...On the following day, eighteen victims were hanged in a cemetery and fourteen more were shot at the cemetery wall by an execution squad of the Wehrmacht's Großdeutschland regiment. Part of the photographic presentation for the book includes a photo in which the Großdeutschland cuff title on an officer is clearly visible. Großdeutschland's complicity in many subsequent war crimes in Russia and Ukraine was a subject of the book by Omer Bartov The Eastern Front, 1941–45, German Troops, and the Barbarization of Warfare (1986, ISBN 0-312-22486-9). Under existing international law at the time, reprisals were permitted, though the Allied nations and Nazi Germany had differing interpretations of the law. In postwar war crimes trials, reprisal killings were deemed to be illegal, a conclusion enshrined in international law by the United Nations.
Rocky Mountain spotted fever, typhus fever and the typhus group, scrub typhus, Q fever, rickettsialpox, and tick fevers caused by Rickettsia, respiratory tract infections caused by Mycoplasma pneumoniae, Lymphogranuloma venereum, trachoma, inclusion conjunctivitis, and uncomplicated urethral, endocervical, or rectal infections in adults caused by Chlamydia trachomatis, psittacosis, non-gonococcal urethritis caused by Ureaplasma urealyticum, relapsing fever due to Borrelia recurrentis, chancroid caused by Haemophilus ducreyi, plague due to Yersinia pestis, tularemia, cholera, campylobacter fetus infections, brucellosis caused by Brucella species (in conjunction with streptomycin), bartonellosis, granuloma inguinale (Klebsiella species), Lyme disease (Borrelia species). Leptospirosis
Sources: en.wikipedia.org
=== Courtship === Following the pioneering work of Alfred Henry Sturtevant and others, Benzer and colleagues used sexual mosaics to develop a novel fate mapping technique. This technique made it possible to assign a particular characteristic to a specific anatomical location. For example, this technique showed that male courtship behavior is controlled by the brain. Mosaic fate mapping also provided the first indication of the existence of pheromones in this species. Males distinguish between conspecific males and females and direct persistent courtship preferentially toward females thanks to a female-specific sex pheromone which is mostly produced by the female's tergites. Male flies sing to the females during courtship using their wings to generate sound, and some of the genetics of sexual behavior have been characterized. In particular, the fruitless gene has several different splice forms, and male flies expressing female splice forms have female-like behavior and vice versa. The TRP channels nompC, nanchung, and inactive are expressed in sound-sensitive Johnston's organ neurons and participate in the transduction of sound. Mutating the Genderblind gene, also known as CG6070, alters the sexual behavior of Drosophila, turning the flies bisexual.
From then on, through to 2016 there was a period of extended stability for the markets, until in April when the large Nucleus marketplace collapsed for unknown reasons, taking escrowed coins with it. On April 28, investigations into the Italian Darknet Community (IDC) forum-based marketplace led to a number of key arrests. In May 2017, the Bloomsfield Market closed after investigations in Slovakia inadvertently led to the arrests of its operators. Later that month, the long-lived Outlaw market closed down citing a major bitcoin cryptocurrency wallet theft; however, speculation remained that it was an exit scam. In July 2017, the markets experienced their largest disruptions since Operation Onymous, when Operation Bayonet culminated in coordinated multinational seizures of both the Hansa and leading AlphaBay markets, sparking worldwide law enforcement investigations. The seizures brought in lots of traffic to other markets making TradeRoute and Dream Market the most popular markets at the time. In October 2017, TradeRoute exit-scammed shortly after being hacked and extorted. In June 2018, the digital security organization Digital Shadows reported that, due to the climate of fear and mistrust after the closure of AlphaBay and Hansa, darknet market activity was switching away from centralized marketplace websites and towards alternatives such as direct chat on Telegram, or decentralized marketplaces like OpenBazaar.
Quantum chemistry can also provide insight into the mechanism of an organic transformation without the collection of any experimental data. Because wavefunctions provide the total energy of a given molecular state, guessed molecular geometries can be optimized to give relaxed molecular structures very similar to those found through experimental methods. Reaction coordinates can then be simulated, and transition state structures solved. Solving a complete energy surface for a given reaction is therefore possible, and such calculations have been applied to many problems in organic chemistry where kinetic data is unavailable or difficult to acquire.
Bromazolam (XLI-268) is a triazolobenzodiazepine (TBZD) which was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. It is the bromo instead of chloro analogue of alprazolam and has similar sedative and anxiolytic effects to it and other benzodiazepines. Bromazolam is a non subtype selective agonist at the benzodiazepine site of GABAA receptors, with a binding affinity of 2.81 nM at the α1 subtype, 0.69 nM at α2 and 0.62 nM at α5. The "common" dosage range for users of bromazolam was reported to be 1–2 mg, suggesting its potency is similar to alprazolam.
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
Solid material is normally kept frozen at about -20 degrees Celsius, desiccated and protected from light. Solutions are held cold and used within a defined window because degradation products accumulate over time.